<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>alteplase</title><link>http://www.unboundmedicine.com/medline/ebm/research/alteplase</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893677/full_citation/Hyperacute_thrombolysis_with_recombinant_tissue_plasminogen_activator_of_acute_ischemic_stroke:_Feasibility_and_effectivity_from_an_Indian_perspective_</link><description>Sharma SR, Sharma N <br/><span class="title">Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective. [Journal Article]</span><br/><span class="source" title="Annals of Indian Academy of Neurology">Ann Indian Acad Neurol 2008 Oct; 11(4):221-4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893677/abstract/Hyperacute_thrombolysis_with_recombinant_tissue_plasminogen_activator_of_acute_ischemic_stroke:_Feasibility_and_effectivity_from_an_Indian_perspective_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893677/full_citation/Hyperacute_thrombolysis_with_recombinant_tissue_plasminogen_activator_of_acute_ischemic_stroke:_Feasibility_and_effectivity_from_an_Indian_perspective_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19893677/Hyperacute_thrombolysis_with_recombinant_tissue_plasminogen_activator_of_acute_ischemic_stroke:_Feasibility_and_effectivity_from_an_Indian_perspective_">Find Related Articles</a> </description></item><item><title>Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893482/full_citation/Paul_Coverdell_National_Acute_Stroke_Registry_Surveillance___four_states_2005_2007_</link><description>George MG, Tong X, McGruder H, et al. <br/><span class="title">Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007. [Journal Article]</span><br/><span class="source" title="MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries / CDC">MMWR Surveill Summ 2009 Nov 6; 58(7):1-23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893482/abstract/Paul_Coverdell_National_Acute_Stroke_Registry_Surveillance___four_states_2005_2007_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893482/full_citation/Paul_Coverdell_National_Acute_Stroke_Registry_Surveillance___four_states_2005_2007_">Full Citation</a></description></item><item><title>Transient Ischemic Attack after Tissue Plasminogen Activator: Aborted Stroke or Unnecessary Stroke Therapy?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893313/full_citation/Transient_Ischemic_Attack_after_Tissue_Plasminogen_Activator:_Aborted_Stroke_or_Unnecessary_Stroke_Therapy</link><description>Uchino K, Massaro L, Hammer MD <br/><span class="title">Transient Ischemic Attack after Tissue Plasminogen Activator: Aborted Stroke or Unnecessary Stroke Therapy? [JOURNAL ARTICLE]</span><br/><span class="source" title="Cerebrovascular diseases (Basel, Switzerland)">Cerebrovasc Dis 2009 Nov 5; 29(1):57-61.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893313/abstract/Transient_Ischemic_Attack_after_Tissue_Plasminogen_Activator:_Aborted_Stroke_or_Unnecessary_Stroke_Therapy">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893313/full_citation/Transient_Ischemic_Attack_after_Tissue_Plasminogen_Activator:_Aborted_Stroke_or_Unnecessary_Stroke_Therapy">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19893313/Transient_Ischemic_Attack_after_Tissue_Plasminogen_Activator:_Aborted_Stroke_or_Unnecessary_Stroke_Therapy">Find Related Articles</a> </description></item><item><title>Baseline Diabetic Status and Admission Blood Glucose Were Poor Prognostic Factors in the EPITHET Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893307/full_citation/Baseline_Diabetic_Status_and_Admission_Blood_Glucose_Were_Poor_Prognostic_Factors_in_the_EPITHET_Trial_</link><description>De Silva DA, Ebinger M, Christensen S, et al. <br/><span class="title">Baseline Diabetic Status and Admission Blood Glucose Were Poor Prognostic Factors in the EPITHET Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cerebrovascular diseases (Basel, Switzerland)">Cerebrovasc Dis 2009 Nov 5; 29(1):14-21.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893307/abstract/Baseline_Diabetic_Status_and_Admission_Blood_Glucose_Were_Poor_Prognostic_Factors_in_the_EPITHET_Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893307/full_citation/Baseline_Diabetic_Status_and_Admission_Blood_Glucose_Were_Poor_Prognostic_Factors_in_the_EPITHET_Trial_">Full Citation</a></description></item><item><title>Efficacy and Safety Profile of the Carotenoid Trans Sodium Crocetinate Administered to Rabbits Following Multiple Infarct Ischemic Strokes: A Combination Therapy Study With Tissue Plasminogen Activator.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891959/full_citation/Efficacy_and_Safety_Profile_of_the_Carotenoid_Trans_Sodium_Crocetinate_Administered_to_Rabbits_Following_Multiple_Infarct_Ischemic_Strokes:_A_Combination_Therapy_Study_With_Tissue_Plasminogen_Activator_</link><description>Lapchak PA <br/><span class="title">Efficacy and Safety Profile of the Carotenoid Trans Sodium Crocetinate Administered to Rabbits Following Multiple Infarct Ischemic Strokes: A Combination Therapy Study With Tissue Plasminogen Activator. [JOURNAL ARTICLE]</span><br/><span class="source" title="Brain research">Brain Res 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891959/abstract/Efficacy_and_Safety_Profile_of_the_Carotenoid_Trans_Sodium_Crocetinate_Administered_to_Rabbits_Following_Multiple_Infarct_Ischemic_Strokes:_A_Combination_Therapy_Study_With_Tissue_Plasminogen_Activator_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19891959/full_citation/Efficacy_and_Safety_Profile_of_the_Carotenoid_Trans_Sodium_Crocetinate_Administered_to_Rabbits_Following_Multiple_Infarct_Ischemic_Strokes:_A_Combination_Therapy_Study_With_Tissue_Plasminogen_Activator_">Full Citation</a></description></item><item><title>Age-dependent Preferential Dense-core Vesicle Exocytosis in Neuroendocrine Cells Revealed by Newly Developed Monomeric Fluorescent Timer Protein.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889833/full_citation/Age_dependent_Preferential_Dense_core_Vesicle_Exocytosis_in_Neuroendocrine_Cells_Revealed_by_Newly_Developed_Monomeric_Fluorescent_Timer_Protein_</link><description>Tsuboi T, Kitaguchi T, Karasawa S, et al. <br/><span class="title">Age-dependent Preferential Dense-core Vesicle Exocytosis in Neuroendocrine Cells Revealed by Newly Developed Monomeric Fluorescent Timer Protein. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular biology of the cell">Mol Biol Cell 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889833/abstract/Age_dependent_Preferential_Dense_core_Vesicle_Exocytosis_in_Neuroendocrine_Cells_Revealed_by_Newly_Developed_Monomeric_Fluorescent_Timer_Protein_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889833/full_citation/Age_dependent_Preferential_Dense_core_Vesicle_Exocytosis_in_Neuroendocrine_Cells_Revealed_by_Newly_Developed_Monomeric_Fluorescent_Timer_Protein_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889833/Age_dependent_Preferential_Dense_core_Vesicle_Exocytosis_in_Neuroendocrine_Cells_Revealed_by_Newly_Developed_Monomeric_Fluorescent_Timer_Protein_">Find Related Articles</a> </description></item><item><title>Acute Ingestion of Long-Chain (n-3) Polyunsaturated Fatty Acids Decreases Fibrinolysis in Men with Metabolic Syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889809/full_citation/Acute_Ingestion_of_Long_Chain__n_3__Polyunsaturated_Fatty_Acids_Decreases_Fibrinolysis_in_Men_with_Metabolic_Syndrome_</link><description>Montegaard C, Tulk HM, Lauritzen L, et al. <br/><span class="title">Acute Ingestion of Long-Chain (n-3) Polyunsaturated Fatty Acids Decreases Fibrinolysis in Men with Metabolic Syndrome. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of nutrition">J Nutr 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889809/abstract/Acute_Ingestion_of_Long_Chain__n_3__Polyunsaturated_Fatty_Acids_Decreases_Fibrinolysis_in_Men_with_Metabolic_Syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889809/full_citation/Acute_Ingestion_of_Long_Chain__n_3__Polyunsaturated_Fatty_Acids_Decreases_Fibrinolysis_in_Men_with_Metabolic_Syndrome_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889809/Acute_Ingestion_of_Long_Chain__n_3__Polyunsaturated_Fatty_Acids_Decreases_Fibrinolysis_in_Men_with_Metabolic_Syndrome_">Find Related Articles</a> </description></item><item><title>Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889106/full_citation/Plasmin_plays_a_key_role_in_the_regulation_of_profibrogenic_molecules_in_hepatic_stellate_cells_</link><description>Martínez-Rizo A, Bueno-Topete M, González-Cuevas J, et al. <br/><span class="title">Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Liver international : official journal of the International Association for the Study of the Liver">Liver Int 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889106/abstract/Plasmin_plays_a_key_role_in_the_regulation_of_profibrogenic_molecules_in_hepatic_stellate_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889106/full_citation/Plasmin_plays_a_key_role_in_the_regulation_of_profibrogenic_molecules_in_hepatic_stellate_cells_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889106/Plasmin_plays_a_key_role_in_the_regulation_of_profibrogenic_molecules_in_hepatic_stellate_cells_">Find Related Articles</a> </description></item><item><title>Partial Intra-Aortic Occlusion Improves Perfusion Deficits and Infarct Size Following Focal Cerebral Ischemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19888934/full_citation/Partial_Intra_Aortic_Occlusion_Improves_Perfusion_Deficits_and_Infarct_Size_Following_Focal_Cerebral_Ischemia_</link><description>Noor R, Wang CX, Todd K, et al. <br/><span class="title">Partial Intra-Aortic Occlusion Improves Perfusion Deficits and Infarct Size Following Focal Cerebral Ischemia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of neuroimaging : official journal of the American Society of Neuroimaging">J Neuroimaging 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19888934/abstract/Partial_Intra_Aortic_Occlusion_Improves_Perfusion_Deficits_and_Infarct_Size_Following_Focal_Cerebral_Ischemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19888934/full_citation/Partial_Intra_Aortic_Occlusion_Improves_Perfusion_Deficits_and_Infarct_Size_Following_Focal_Cerebral_Ischemia_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1552-6569.2009.00436.x http://dx.doi.org/10.1111/j.1552-6569.2009.00436.x">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19888934/Partial_Intra_Aortic_Occlusion_Improves_Perfusion_Deficits_and_Infarct_Size_Following_Focal_Cerebral_Ischemia_">Find Related Articles</a> </description></item><item><title>Intracameral recombinant tissue plasminogen activator for refractory glaucoma secondary to a fungal corneal abscess.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19888435/full_citation/Intracameral_recombinant_tissue_plasminogen_activator_for_refractory_glaucoma_secondary_to_a_fungal_corneal_abscess_</link><description>Katz LJ, Stirbu O, Willis G, et al. <br/><span class="title">Intracameral recombinant tissue plasminogen activator for refractory glaucoma secondary to a fungal corneal abscess. [Journal Article]</span><br/><span class="source" title="The open ophthalmology journal">Open Ophthalmol J 2009.:75-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19888435/abstract/Intracameral_recombinant_tissue_plasminogen_activator_for_refractory_glaucoma_secondary_to_a_fungal_corneal_abscess_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19888435/full_citation/Intracameral_recombinant_tissue_plasminogen_activator_for_refractory_glaucoma_secondary_to_a_fungal_corneal_abscess_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19888435/Intracameral_recombinant_tissue_plasminogen_activator_for_refractory_glaucoma_secondary_to_a_fungal_corneal_abscess_">Find Related Articles</a> </description></item></channel></rss>